What is Travis Cleanair?
Travis Cleanair, Inc. operates at the intersection of advanced manufacturing and regulatory compliance, providing modular cleanroom solutions and buffer room suites. The company is uniquely positioned to address the stringent requirements of USP 797 and USP 800 guidelines, which are critical for pharmaceutical and high-tech manufacturing sectors. By offering a comprehensive suite of services—ranging from initial consulting and bespoke design to final installation—the company ensures that its clients maintain operational integrity while scaling their production capabilities. Their U.S.-manufactured modular systems provide the flexibility required by modern enterprises to adapt to evolving cleanroom standards without the downtime associated with traditional construction methods.
How much funding has Travis Cleanair raised?
Travis Cleanair has raised a total of $739K across 2 funding rounds:
Debt
$350K
Debt
$389K
Debt (2020): $350K with participation from PPP
Debt (2021): $389K led by PPP
Key Investors in Travis Cleanair
PPP
Public-Private Partnership
What's next for Travis Cleanair?
With the infusion of this recent capital, Travis Cleanair is expected to prioritize the expansion of its manufacturing footprint and the enhancement of its modular design portfolio. The strategic focus will likely shift toward scaling production to meet the rising demand for compliant cleanroom environments in the pharmaceutical industry. Furthermore, the company is well-positioned to invest in R&D to refine its cleanroom configurations, ensuring that its offerings remain at the forefront of industry compliance. As the firm continues to mature, this funding serves as a catalyst for broader market penetration and the potential development of next-generation modular office and laboratory solutions, reinforcing its role as a critical partner for enterprises navigating complex regulatory landscapes.
See full Travis Cleanair company page
